Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 4:40 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1105–1128 of 9,992 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: TARGET Clear all

Conditions: Teaching Behaviors, Sign Language Skills
Interventions: Strategic and Interactive Signing Instruction; Behavioral
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 4 Years to 99 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Metastatic Castration-resistant Prostate Cancer
Interventions: MSGV1-PSCA-8T28Z, Fludarabine, Cyclophosphamide; Biological · Drug
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2033
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Schizophrenia
Interventions: 20 Hz rTMS; Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: Indianapolis, Indiana

Conditions: Neuropathic Pain, Low Back Pain
Interventions: Spinal Cord Stimulation; Device
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 90 Years
Enrollment: 6 participants
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Allogeneic Hematopoietic Stem Cell Transplantation
Interventions: IFN-gamma-secreting HAdV antigen specific T cells; Biological
Lead sponsor: Mari Dallas; Other
Eligibility: 3 Months and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Influenza, Human
Interventions: Flu shot text messages; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 74,811 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 2
States / cities: Danville, Pennsylvania • Philadelphia, Pennsylvania

Conditions: Families Experiencing Homelessness With Children Under 48 Months of Age
Interventions: Healthy Home, Attachment and Biobehavioral Catch-up Infant (6-24 months) and Toddler (24-48 months)., HealthySteps; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Triple Negative Breast Cancer, Non Small Cell Lung Cancer, Metastatic Breast Cancer, Metastatic Non-Small Cell Lung Carcinoma
Interventions: Stereotactic Body Radiotherapy/SBRT, Systemic Therapy/Standard of Care; Radiation · Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 12
States / cities: San Carlos, California • Hartford, Connecticut • Norwalk, Connecticut + 9 more

Conditions: COVID-19
Interventions: RD-X19, Sham; Device
Lead sponsor: EmitBio Inc.; Industry
Eligibility: 40 Years and older
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 48
States / cities: Mesa, Arizona • Phoenix, Arizona • Anaheim, California + 42 more

Conditions: Skin Aging, Weight Loss
Interventions: Revival Soy Dietary Supplement; Behavioral
Lead sponsor: Physicians Pharmaceuticals, Inc.; Industry
Eligibility: 25 Years to 45 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: High Point, North Carolina

Conditions: Malignant Brain Neoplasm, Recurrent Malignant Brain Neoplasm, Refractory Malignant Brain Neoplasm
Interventions: Cyclophosphamide, Fludarabine, IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes; Drug · Biological
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 4 Years to 25 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 3
States / cities: Duarte, California • Los Angeles, California • Ann Arbor, Michigan

Conditions: Neuroendocrine Tumors
Interventions: AlphaMedix; Drug
Lead sponsor: Orano Med LLC; Industry
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2030
U.S. locations: 4
States / cities: Denver, Colorado • Tampa, Florida • Metairie, Louisiana + 1 more

Conditions: Spinal Cord Injury
Interventions: Genital nerve stimulation; Device
Lead sponsor: MetroHealth Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Prostate Cancer, Recurrent Adenocarcinoma, Liver Cancer, Head and Neck Cancer
Interventions: MRI Simulator, Radiation Therapy; Device · Radiation
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2030
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Dehydration
Interventions: Distilled water, Medical Food 1, Medical Food 2, Pedialyte, Gatorade; Other
Lead sponsor: W. Larry Kenney; Other
Eligibility: 18 Years to 90 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Liver Cancer
Interventions: stereotactic body radiation therapy; Radiation
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years to 120 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2017
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Obesity, Overweight
Interventions: Enriched lifestyle intervention; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 13 Years to 15 Years · Female only
Enrollment: 215 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Dementia, Alzheimer Disease, Infections
Interventions: TRAIN AD 2.0; Behavioral
Lead sponsor: Hebrew SeniorLife; Other
Eligibility: 60 Years to 106 Years
Enrollment: 750 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Parkinson's Disease
Interventions: Varenicline, Placebo; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 45 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Autism Spectrum Disorder
Interventions: JASPER, JASPER Plus+; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 24 Months to 36 Months
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Langerhans Cell Histiocytosis
Interventions: Trametinib; Drug
Lead sponsor: Cook Children's Health Care System; Other
Eligibility: 1 Year to 30 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2039
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Melanoma, Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma of the Skin, Sarcoma of the Skin, Basal Cell Cancer of the Skin, Breast Cancer
Interventions: Poly-ICLC; Drug
Lead sponsor: Nina Bhardwaj; Other
Eligibility: 14 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Diabetes, Diabetes Mellitus, Type 2
Interventions: insulin degludec, insulin glargine; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 1,030 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 86
States / cities: Bay Minette, Alabama • Birmingham, Alabama • Huntsville, Alabama + 80 more

Conditions: Substance Use Disorders, Drug Abuse, Alcohol Abuse, Posttraumatic Stress Disorder, PTSD, Recidivism, Depression
Interventions: Cognitive Processing Therapy, Control Group; Behavioral
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Enrollment: 148 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 2
States / cities: Osceola, Arkansas • West Memphis, Arkansas

Search by objective public record fields.

Strategic and Interactive Signing Instruction

Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC

Interactions of Fronto-Parietal High Frequency rTMS on Anterior Cingulate Cortex Activation in Schizophrenia

Quality of Life Outcomes in Spinal Cord Stimulation

Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation

Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates

Collaboration to Promote Early Childhood Well Being in Families Experiencing Homelessness

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

Effect of Revival Soy on Weight Loss and Skin, Hair, and Nails in Premenopausal Women

CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children

Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients

At-Home Genital Nerve Stimulation for SCI Bowel

Jump: MR Simulation For Radiation Therapy Master Protocol

Effects of Amino Acid/Electrolyte-based Beverages on Hydration Status

Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer

Examining the Feasibility of Collaborative Care Treatment for Overweight Adolescents

Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0

Crossover Target Engagement Study of Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease (Project #3 - Experiment 3 [UdallP3E3])

Community-based Adaptive Autism Intervention for Toddlers

Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib

Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)

Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes

Leveraging Implementation Science to Increase Access to Trauma Treatment for Incarcerated Drug Users